Cargando…
Pancreatitis in Acute Promyelocytic Leukemia: Drug-induced or Differentiation Syndrome?
Acute promyelocytic leukemia (APL) constitutes about 15% of all acute myeloid leukemia patients and can now be treated even without any chemotherapy, with all-trans-retinoic acid (ATRA) and arsenic trioxide (ATO). Acute pancreatitis (AP) is a rare adverse event in APL, which is primarily reported to...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686987/ https://www.ncbi.nlm.nih.gov/pubmed/29200694 http://dx.doi.org/10.4103/ijmpo.ijmpo_36_16 |